
    
      Single-center, open label, non-randomized safety and efficacy trial to evaluate
      co-transplantation of allogeneic parathyroid glands (PTG) with adult pancreatic islets (both
      PTG and pancreatic islets obtained from same deceased donor) in people with Type 1 diabetes
      in the intramuscular (IM) site with stable function of liver or kidney allografts on chronic
      immunosuppression.

      A total of 8 patients will be enrolled in the study and followed for a minimum of 1 year up
      to 2 years after the last islet transplant, depending on enrollment date.
    
  